US President Trump says the number of drugs available on TrumpRx is to be increased by nearly 7 times with over 600 generics to be added to TrumpRx

President Trump's announcement about expanding TrumpRx significantly increases the availability of generic drugs, which may have implications for healthcare costs and spending in the U.S. This move could potentially affect investor sentiment towards healthcare equities and influence broader market dynamics, particularly if it is seen as a step towards lowering prescription costs. Watch how this announcement resonates across sectors, particularly in healthcare and consumer goods.